+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06274515

Multi-Cohort Translational Research on Breast Cancer Therapy Resistance Investigating Tumor and Blood Biomarkers in Progressive Breast Cancer

Led by Hoffmann-La Roche · Updated on 2026-11-03

320

Participants Needed

28

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating why some breast cancers resist anti-cancer treatments by studying tumor tissue and blood samples from participants with HER2 positive, hormone receptor positive, or triple negative breast cancer. This research focuses on understanding mechanisms of resistance in patients who have either newly appearing or progressing metastatic lesions while undergoing therapy. The study is designed as a Phase 4 interventional trial with multiple participant groups based on disease progression and resistance patterns. Participants are assigned to different groups depending on whether they have newly appearing or recurrent metastatic lesions while on treatment, or if their tumor lesions are progressing during therapy. The study involves collecting tumor tissue and blood samples at the time of disease progression or recurrence to measure changes in HER2 protein and gene levels, estrogen receptor protein levels, genes related to resistance, and immune markers. These procedures help researchers understand resistance mechanisms related to various breast cancer therapies. During the study, participants will have blood drawn on the same day a tumor tissue sample is taken from a progressive lesion. Researchers will monitor changes over periods of at least six months or less, depending on the cohort. Assessments include molecular and immune profiling to track resistance development. Participants are expected to be involved in procedures to obtain tissue and blood samples, with safety and progression carefully monitored throughout the trial, which is planned to continue until early 2028.

CONDITIONS

Brief Title

A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies

Research Team

R

Reference Study ID Number: WO44977 https://forpatients.roche.com/ No attachments to email below.

F

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here